A detailed history of Royal Bank Of Canada transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 8,419 shares of PTCT stock, worth $389,294. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,419
Previous 7,213 16.72%
Holding current value
$389,294
Previous $220,000 41.82%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$30.39 - $37.66 $36,650 - $45,417
1,206 Added 16.72%
8,419 $312,000
Q2 2024

Aug 14, 2024

BUY
$24.69 - $40.12 $109,105 - $177,290
4,419 Added 158.16%
7,213 $220,000
Q1 2024

Nov 05, 2024

SELL
$24.15 - $31.95 $106,718 - $141,187
-4,419 Reduced 61.26%
2,794 $81,000
Q1 2024

May 15, 2024

SELL
$24.15 - $31.95 $455,662 - $602,832
-18,868 Reduced 87.1%
2,794 $81,000
Q4 2023

Feb 14, 2024

BUY
$18.07 - $29.37 $212,991 - $346,184
11,787 Added 119.36%
21,662 $597,000
Q3 2023

Nov 14, 2023

BUY
$22.41 - $41.99 $77,000 - $144,277
3,436 Added 53.36%
9,875 $221,000
Q2 2023

Aug 14, 2023

SELL
$40.4 - $59.1 $147,136 - $215,242
-3,642 Reduced 36.13%
6,439 $261,000
Q1 2023

May 15, 2023

SELL
$38.16 - $48.86 $207,475 - $265,651
-5,437 Reduced 35.04%
10,081 $488,000
Q4 2022

Feb 14, 2023

BUY
$33.53 - $54.79 $376,843 - $615,784
11,239 Added 262.65%
15,518 $592,000
Q3 2022

Nov 14, 2022

SELL
$41.85 - $53.85 $53,526 - $68,874
-1,279 Reduced 23.01%
4,279 $215,000
Q2 2022

Aug 15, 2022

SELL
$25.6 - $45.23 $304,230 - $537,513
-11,884 Reduced 68.13%
5,558 $222,000
Q1 2022

May 16, 2022

SELL
$33.33 - $44.6 $385,261 - $515,531
-11,559 Reduced 39.86%
17,442 $651,000
Q4 2021

Feb 14, 2022

BUY
$35.36 - $41.86 $69,093 - $81,794
1,954 Added 7.22%
29,001 $1.16 Million
Q3 2021

Nov 15, 2021

SELL
$37.01 - $44.74 $24,241 - $29,304
-655 Reduced 2.36%
27,047 $1.01 Million
Q2 2021

Aug 16, 2021

BUY
$37.95 - $49.37 $1.05 Million - $1.37 Million
27,702 New
27,702 $1.17 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.31B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.